|
DEVELOPING ALTERNATIVE APPROACHES TO REDUCE RETINAL TOXICITY AND PREVENT VISION LOSS IN THE TREATMENT OF INTRAOCULAR RETINOBLASTOMA |
1K08EY027464-01 |
DANIELS, ANTHONY BRENT |
NEI |
2017 |
|
ADDRESSING LOW VISION DUE TO SEVERE PERIPHERAL FIELD LOSS: DEVELOPMENT AND VALIDATION OF A PATIENT-CENTERED OUTCOME MEASURE |
1K23EY027848-01 |
EHRLICH, JOSHUA ROBERT |
NEI |
2017 |
|
VISION DEFECTS ASSOCIATED WITH LOSS OF C-VPS FUNCTION |
1R01EY026551-01A1 |
THUMMEL, RYAN |
NEI |
2017 |
|
OPTIMAL MAGNIFICATION AND OCULOMOTOR STRATEGIES IN LOW VISION PATIENTS |
1R01EY026617-01A1 |
MASSOF, ROBERT W. |
NEI |
2017 |
|
PATHOGENIC B CELL AND T HELPER CELL INTERACTIONS IN NEUROMYELITIS OPTICA |
1R01EY027346-01 |
AXTELL, ROBERT C |
NEI |
2017 |
|
VISUAL CORTEX PLASTICITY IN BLINDNESS: A WINDOW INTO FLEXIBILITY OF HUMAN CORTEX |
1R01EY027352-01A1 |
BEDNY, MARINA |
NEI |
2017 |
|
MECHANISMS OF INFLAMMATION RESOLUTION IN BACTERIAL ENDOPHTHALMITIS |
1R01EY027381-01 |
KUMAR, ASHOK |
NEI |
2017 |
|
INTRAVENOUS MITOTARGETED AAV9 GENE THERAPY FOR TREATMENT OF VISUAL LOSS AND ENCEPHALOPATHY IN LEIGH SYNDROME AND NARP |
1R01EY027414-01 |
GUY, JOHN |
NEI |
2017 |
|
RAPALOG THERAPY IN HERITABLE AND VIGABATRIN-INDUCED GABA METABOLIC DISORDERS |
1R01EY027476-01 |
GIBSON, K MICHAEL |
NEI |
2017 |
|
DIAGNOSTIC INNOVATIONS IN GLAUCOMA STUDY (DIGS): HIGH MYOPIA AND ADVANCED DISEASE |
1R01EY027510-01 |
ZANGWILL, LINDA M |
NEI |
2017 |